Event Moderator: Jacqui Thornton – Global Health Journalist 

9.00 – 9.40 – Opening Session 

  • Welcome to the conference: Finn-Jarle Rode, Executive Director, The Hepatitis Fund 
  • Welcome video message: Dr Chelsea Clinton, Board of Directors, Clinton Health Access Initiative
  • Honorary Guest: Dr Al-Issa, H.E. Secretary General, Muslim World League
  • Opening Remarks: Prof Michel Kazatchkine, Senior Fellow, Global Health Center, The Graduate Institute for International Affairs and Development, Geneva


9:40 – 10:10 – Session One: Supporting Hepatitis Elimination – Hosts And Partners Remarks  

Chair: Gregg Alton, Chairman Board of Directors, The Hepatitis Fund

  • Rakan Khalid Bin Dohaish, Assistant Deputy Minister for International Collaborations, Ministry of Health, Kingdom of Saudi Arabia
  • H.E. Dr Khaled Abdel Ghaffar, Minister of Health, Arab Republic of Egypt (video message)
  • Dr Manal El-Sayed, Representative Minister of Health, Arab Republic of Egypt 
  • Dr Tedros Adhanom Ghebreyesus, Director General, World Health Organization (video message)
  • Dr David Ripin, Executive Vice President, Infectious Diseases; Chief Science Officer, Clinton Health Access Initiative

10:10 – 10:40 – Session Two: Call to Action – Voices Of The Community  

  • Kenneth Kabagambe – Hepatitis Advocate, Uganda 
  • Anton Basenko – Harm Reduction Services and Integrated HIV and Hepatitis Care, Ukraine
  • Raquel Peck – Living and being cured from HCV, England | Brazil
  • Sister Annie Kanunga – Caring for people who live with HBV, Zambia
  • Video message: Joelle Dountio, Acting HCV Project Director, Treatment Action Group

10:40 – 11:10 – Session Three: The Case For Hepatitis Elimination – Expert Opinions  

Chair: Dr Su Wang, Person who lives with HBV and Medical Director of the Center for Asian Health at Saint Barnabas Medical Center, US

  • Dr Meg Doherty, Director of WHO’s Global HIV, Hepatitis, and Sexually Transmitted Infections Programmes – Viral Hepatitis Elimination, an SDG we can reach
  • Dr Homie Razavi, Managing Director of the Center for Disease Analysis Foundation – The Hepatitis Elimination Investment Case

11:10 – 11:30 – Coffee Break  

11:30 – 12:45 – Session Four: Country Experiences  

Chair: Oriel Fernandes, Senior Director, Viral Hepatitis, Clinton Health Access Initiative, and Naomi Burke-Shyne, Executive Director, Harm Reduction International

  • Dr Keo Samley, Vice Chief of Bureau Prevention and Control of Communicable Disease Control Department, Ministry of Health, Cambodia
  • Dr Akudo Ikpeazu, National Coordinator, National AIDS, Viral Hepatitis and STIs Control Programme, Federal Ministry of Health, Nigeria.
  • Dr Baseer Khan Achakzai, Director General Health, Ministry of Health, Pakistan
  • Dr Gallican Rwibasira, Head of National HIV, STIs and Hepatitis Programs, Ministry of Health, Rwanda
  • Dr Daniel Kyabayinze, Director of Public Health, Ministry of Health, Uganda
  • Dr Lloyd Mulenga, Director of Infectious Diseases, Ministry of Health, Zambia

12:45 – 13:45  Lunch Break  

13:45 – 14:45 – Session Five: Access To Diagnostics And Treatment – The Role Of Industry  

Chair: Dr David Ripin, Executive Vice President, Infectious Diseases; Chief Science Officer, Clinton Health Access Initiative

  • Panel Discussion:
    • Sophia Chao, Lifecycle Leader for Infectious Disease, Roche
    • Dr Francesco Marinucci, Director, Global Market Access & Funding, Abbott
    • Tiffany Clarke, Director, Global Health Strategy, Hologic
    • Rachel O’Shea, Vice President for Global Market Access, Cepheid
    • Kedar Madhekar, Associate Vice President – Strategic Initiatives & Commercial Operations, Viatris
    • Rahul Lande, Vice President of Global Access Division, Hetero
    • Charles Gore, Executive Director, Medicines Patent Pool
  • Company Commitments

14:45 – 15:00 – Coffee Break  

15:00 – 16:20 – Session Six: Commitments And Announcements  

  • Organizational Investments | Direct Programmatic Commitments:  
    • Dr Siobhan Crowley, Global Fund to Fight AIDS, Tuberculosis and Malaria  
    • Dr Mohammed Abdulaziz, Africa Centres for Disease Control and Prevention 
    • Dr Karin Timmermans, UNITAID 
    • Dr George Siberry, USAID
    • Dr Bill Rodriguez, FIND
  • Country Domestic Commitments
    • Dr Emmanuel Akabe, Deputy Governor of Nasarawa State, Nigeria
    • Dr Mario Gonzalez, Coordinator of Viral Hepatitis National Programme, Brazil
    • Dr Baseer Khan Achakzai, Director General Health, Ministry of Health, Pakistan
  • Monetary Pledges to The Hepatitis Fund

16:20 – 16:30 – Closing Session 

  • Dr Manal El-Sayed, Board of Directors, The Hepatitis Fund 
  • Nathalie Fontanet, Geneva State Councillor of the Department of Finance and Human Resources, in charge of International Affairs